Buyers of the provider of critical communications software have been more aggressive for months now, but we may see a correction near term.
Charts and indicators tell us CHGG's rally has further to go.
The charts and indicators of ARE are heading in the right direction but not with convincing volume.
Let's see what strategy makes sense today.
EBS has been in an uptrend for a long time.
This biotech is on the front lines of oncology treatments.
Let's check out the charts and indicators of EL.
Trading volume in the disinfectant maker's shares has been very active since February, which coincides with rising coronavirus fears.
Avoid the long side for now.
I don't see clear signs of aggressive buying.